Data as of Aug 29
| +0.045 / +2.41%|
The 1 analysts offering 12-month price forecasts for Avita Medical Ltd have a median target of 3.64, with a high estimate of 3.64 and a low estimate of 3.64. The median estimate represents a +90.29% increase from the last price of 1.92.
The current consensus among 1 polled investment analysts is to Buy stock in Avita Medical Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.